| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 05/01/2001 | US6225330 For treatment of abnormal conditions such as feeding disorders (obesity and bulimia nervosa), sexual/reproductive disorders, depression, epileptic seizure, hypertension, cerebral hemorrhage, congestive heart failure, sleep disturbances |
| 05/01/2001 | US6225326 Administering insulin sensitivity enhancer in combination with an .alpha.-glucosidase inhibitor for therapy to reduce side effect for diabetic patient |
| 05/01/2001 | US6225323 Activated iododerivatives for the treatment of cancer and AIDS |
| 05/01/2001 | US6225305 Substituted urea and isothiorea derivatives as no synthase inhibitors |
| 05/01/2001 | US6225023 Sulfonamide compound and method for its production, metal chelate compound employing the sulfonamide compound, and optical recording medium employing the metal chelate compound |
| 05/01/2001 | US6224849 Alkylaminobenzothiazole and-benzoxazole derivatives |
| 04/26/2001 | WO2001028991A1 N-cycloalkyl thiooxamide derivatives |
| 04/26/2001 | WO2001028987A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 04/26/2001 | WO2000055125A3 N-cyanomethyl amides as protease inhibitors |
| 04/26/2001 | US20010000512 Fungicides |
| 04/26/2001 | US20010000511 Treatment of skin disorders, inflammation, nerve system disorders, cancer |
| 04/26/2001 | CA2384240A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 04/25/2001 | EP1093367A1 Protease inhibitors |
| 04/25/2001 | CN1064961C Preparation method of substituted thiazoles |
| 04/24/2001 | US6222057 Reacting 1,3-dichloropropene and thiocyanate salt in watr or organic solvent in presence of phase transfer catalyst to form 2-chloro-5-chloromethyl-1,3-thiazole |
| 04/24/2001 | US6222044 Reacting an aromatic aldehyde with hydroxylamine to form an aromatic aldehyde oxime, halogenating oxime to form aromatic hydroxamoyl halide, and reacting with aromatic amine compounds to form benzoxazole, benzothiaxole, benzimidazoles |
| 04/24/2001 | US6222043 Coupling 2-amido-thiazole derivative with 2-phenyl4-(protected)amino-butyric acid; deprotecting amino protecting group; acylating product with carboxylic acid containing carbocyclic or heterocyclic group; deprotecting |
| 04/24/2001 | US6222041 Method for the production of 2-mercaptobenzothiazole |
| 04/24/2001 | US6222040 Selective NPY (Y5) antagonists (tricyclics) |
| 04/24/2001 | US6221911 Reducing subcutaneous fat deposits in a subject; improving the skin condition of a subject |
| 04/24/2001 | US6221881 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 04/24/2001 | US6221865 Inhibitors of protein farnesyltransferase and protein geranylgeranyltransferase. |
| 04/19/2001 | WO2001027308A2 13-alkyl epothilone derivatives |
| 04/19/2001 | WO2001027145A1 Antibody catalysis of enantio- and diastereo-selective aldol reactions |
| 04/19/2001 | WO2001027107A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/19/2001 | WO2001027096A1 Aminomethyl-(hetero)aryl derivatives and their use as tryptase inhibitors |
| 04/19/2001 | WO2001027095A1 Method for producing 2-(n-boc-aminomethyl)-thiazol-4-carboxylic acid |
| 04/19/2001 | WO2001027094A1 Hypertriglyceridemia remedies and antiobestics |
| 04/19/2001 | WO2001027084A1 Beta disubstituted metalloprotease inhibitors |
| 04/19/2001 | WO2001027068A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 04/19/2001 | WO2001026656A2 5-membered heterocycle derivatives and use thereof as monoamine oxidase inhibitors |
| 04/19/2001 | WO2000018767A9 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands |
| 04/19/2001 | US20010000345 Compounds such as (4,7-dimethylbenzimidazol-5-yl)guanidine; treating nasal congestion, otitis media, asthma, pain, migraine, gastrointestinal disorder, ulcer |
| 04/19/2001 | DE19949569A1 Verfahren zur Herstellung von 2-(N-BOC-Aminomethyl)-thiazol-4-carbonsäure A process for the preparation of 2- (N-BOC-aminomethyl) thiazole-4-carboxylic acid |
| 04/19/2001 | CA2425620A1 13-alkyl epothilone derivatives |
| 04/19/2001 | CA2388813A1 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/19/2001 | CA2388505A1 5-membered heterocycle derivatives, their preparation and application as medicine |
| 04/19/2001 | CA2386485A1 Beta disubstituted metalloprotease inhibitors |
| 04/18/2001 | EP1092711A1 Retinoid-associated receptor regulators |
| 04/18/2001 | EP1091946A1 New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use |
| 04/18/2001 | EP1091943A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/18/2001 | EP1091937A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 04/18/2001 | EP1091648A1 Biocidal composition and its use |
| 04/18/2001 | CN1291982A Nitrate salt of anti-ulcer medicine |
| 04/18/2001 | CN1291973A N-sulphonyl and N-sulphinyl phenylglycinamide |
| 04/18/2001 | CN1291612A Cynnematin kind antibiotics |
| 04/18/2001 | CN1291611A Cynnematin kind antibiotics |
| 04/18/2001 | CA2323311A1 New process for the preparation of retiferol derivatives |
| 04/17/2001 | US6218544 Heterocyclic esters and amides |
| 04/17/2001 | US6218431 Substituted biphenyls |
| 04/17/2001 | US6218429 Tricyclic compounds, their production and use |
| 04/17/2001 | US6218409 Administering insulin sensitivity enhancer in combination with an aldose reductase inhibitor for reducing side effects of diabetic drugs |
| 04/17/2001 | US6218408 Selective NPY (Y5) antagonists (bicyclics) |
| 04/17/2001 | US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices |
| 04/17/2001 | US6218359 Treating autoimmune, arthritic, tumor diseases |
| 04/17/2001 | US6217845 Protein labelling |
| 04/17/2001 | CA2158457C Naphthalene derivatives |
| 04/12/2001 | WO2001025242A1 Novel thiazolo(4,5-d)pyrimidine compounds |
| 04/12/2001 | WO2001025181A1 Carboxylic acid derivatives and drugs containing the same |
| 04/12/2001 | WO2001024828A2 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | WO2001024827A2 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | DE19948269A1 New compounds as integrin antagonists useful for treating e.g. cardiovascular disorders, rheumatoid arthritis, kidney failure, stroke, cancer, osteoporosis, psoriasis or infection |
| 04/12/2001 | DE19948101A1 New substituted aryl- and heteroaryl-alkanes are serine protease and thrombin inhibitors, used for treatment of e.g. deep vein thrombosis or stroke |
| 04/12/2001 | CA2386457A1 Inhibitors of the endothelin signalling pathway and .alpha.v.beta.3 integrin receptor antagonists for combination therapy |
| 04/11/2001 | EP1090968A1 Coating composition and method for preparing the same, and scuff-resistant plastic lense |
| 04/11/2001 | EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/11/2001 | EP1090912A1 Amino acid derivatives and drugs containing the same as the active ingredient |
| 04/11/2001 | EP1089990A1 1-(benzothiazol-2-yl)-4-(1-phenylmethyl)piperazines: dopamine receptor subtype specific ligands |
| 04/11/2001 | EP1089989A1 Inhibitors of alpha4beta1 mediated cell adhesion |
| 04/11/2001 | EP1089964A1 Hydrazine derivatives |
| 04/11/2001 | EP1089963A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release |
| 04/11/2001 | EP0866704B1 Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis |
| 04/11/2001 | CN1291183A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 04/11/2001 | CN1291100A Cyclopentane Heptan (ene) oic acid, 2-hetero arylakenyl derivatives and therapeutic agents |
| 04/11/2001 | CN1064350C Aryl and heteroaryl alkoxynaphtalene derivatives |
| 04/10/2001 | US6214998 Process for preparing 2-chloro-5-chloromethylthiazole |
| 04/10/2001 | US6214997 Reacting ethyl 2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetate with t-butyl 2-bromoisobutyrate, converting the ethyl ester to the free acid and tritylating, and precipitating with n,n-dimethylformamide; intermediate to ceftazidime |
| 04/10/2001 | US6214994 Treatment of neoplastic diseases, bacterial or fungal infections, and preventing or decreasing production of phosphorylated paired helical filament (phf) epitopes associated with alzheimer's disease |
| 04/10/2001 | US6214880 Lowering plasma cholesterol levels and inhibiting abnormal cell proliferation with said compound; treatment of cancer, psoriasis, vascular restenosis, infections, atherosclerosis and hypercholesterolemia |
| 04/10/2001 | US6214853 Selective NPY (Y5) antagonists (bicyclics) |
| 04/10/2001 | US6214852 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 04/10/2001 | US6214851 N-adamant-1-y1-N1-[4-chlorobenzothiazol-2-y1] urea useful in the treatment of inflammation and as an anticancer radiosensitizing agent |
| 04/10/2001 | US6214848 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action for prophylaxis and treatment of diabetes; depressing diabetic hyperglycemia |
| 04/10/2001 | US6214842 Treating metabolic disorders related to insulin resistance or hyperglycemia typically associated with obesity or glucose intolerance; treating diabetes types i and ii |
| 04/10/2001 | US6214835 Dihalopropene compounds insecticides containing them as active ingredients, and intermediates for their production |
| 04/05/2001 | WO2001023363A1 Sulfonamide derivatives |
| 04/05/2001 | WO2001023349A1 Acylsulfonamide derivatives |
| 04/05/2001 | WO2001023340A1 Method for preparing 2-chloropropionaldehyde and use of the same |
| 04/05/2001 | WO2000057877A8 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof |
| 04/05/2001 | US20010000178 Pyridyl substituted thiazoles |
| 04/05/2001 | US20010000177 Novel class of thiomorpholino substituted thiazoles |
| 04/04/2001 | EP1087975A2 Epothilone minor constituents |
| 04/04/2001 | EP1087952A1 Benzazole compounds and their use |
| 04/04/2001 | EP1087951A1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
| 04/04/2001 | EP1087941A2 Thiolesters and uses thereof |
| 04/04/2001 | EP1087934A1 Aminocyclohexyl ether compounds and uses thereof |
| 04/04/2001 | EP0576667B1 Test kit and method for the determination of pesticides |
| 04/04/2001 | CN1290166A Treatment of Dyskinesie |
| 04/04/2001 | CN1290165A Benzothiazole Protein tyrosine kinase inhibitors |
| 04/04/2001 | CN1290164A Inhibition of RAF kinase using substituted heterocyclic ureas |